|
nasdaq:otic
|
1495724
|
Apr 14th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 13th, 2024 11:30PM
|
Apr 13th, 2024 11:30PM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 13th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 12th, 2024 11:22PM
|
Apr 13th, 2024 11:56AM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 12th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 11th, 2024 11:28PM
|
Apr 12th, 2024 08:51AM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 11th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 11th, 2024 12:00AM
|
Apr 11th, 2024 11:36AM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 10th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 9th, 2024 11:30PM
|
Apr 10th, 2024 05:44PM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 9th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 8th, 2024 11:40PM
|
Apr 9th, 2024 10:25AM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 8th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 8th, 2024 12:05AM
|
Apr 8th, 2024 07:22PM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 7th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 6th, 2024 11:35PM
|
Apr 6th, 2024 11:35PM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 6th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 5th, 2024 11:35PM
|
Apr 5th, 2024 11:35PM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:otic
|
1495724
|
Apr 5th, 2024 12:00AM
|
Otonomy, Inc
|
2.9K
|
14.00
|
Open
|
|
Apr 5th, 2024 12:03AM
|
Apr 5th, 2024 12:03AM
|
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
|
Open
|
|
Open
|
4796 Executive Dr
|
San Diego
|
CA
|
US
|
92121
|
|
Otonomy
|
Health Care
|
Pharmaceuticals & Biotechnology
|